Regulus Therapeutics Reports Third Quarter 2021 Financial Results and Recent Updates

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. MU
5. USO
6. GOOGL
7. APGE
8. NAVN
9. DFTX
10. IBM

Go back to Regulus Therapeutics Reports Third Quarter 2021 Financial Results and Recent Updates
REGULUS THERAP (NASDAQ: RGLS) Delayed: 8.16 --0 (-0%)
Previous Close $8.16    52 Week High $10.60 
Open $8.16    52 Week Low $2.13 
Day High $8.16    P/E 0.21 
Day Low $8.16    EPS $38.45 
Volume 1